We are live on ! Find out more
GS

GAM Systematic Portfolio holdings

AUM $696M
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+28.4%
3 Year Est. Return
+67.26%
5 Year Est. Return
10 Year Est. Return
AUM
$697M
AUM Growth
+$188M
Cap. Flow
+$170M
Cap. Flow %
24.45%
Top 10 Hldgs %
6.46%
Holding
682
New
100
Increased
341
Reduced
131
Closed
109

Top Sells

Rank Stock Value
1
CSL icon
Carlisle Companies
CSL
+$1.5M
2
OTEX icon
Open Text
OTEX
+$1.34M
3
AXS icon
AXIS Capital
AXS
+$1.25M
4
SYF icon
Synchrony
SYF
+$1.21M
5
DNB
Dun & Bradstreet
DNB
+$1.18M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Industrials 18.92%
3 Consumer Discretionary 14.07%
4 Healthcare 11.83%
5 Financials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
126
S&P Global
SPGI
$124B
$1.85M 0.27%
12,681
+10,404
+457% +$1.44M
ESRX
127
DELISTED
Express Scripts Holding Company
ESRX
$1.85M 0.27%
28,941
+13,467
+87% +$846K
NYT icon
128
New York Times
NYT
$11.4B
$1.84M 0.26%
103,942
+49,650
+91% +$816K
SCI icon
129
Service Corp International
SCI
$10.9B
$1.84M 0.26%
54,966
+6,854
+14% +$218K
PG icon
130
Procter & Gamble
PG
$342B
$1.83M 0.26%
20,953
+1,623
+8% +$143K
ACH
131
Accendra Health
ACH
$240M
$1.82M 0.26%
56,571
+19,640
+53% +$645K
ALSN icon
132
Allison Transmission
ALSN
$9.92B
$1.81M 0.26%
48,394
+33,520
+225% +$1.25M
TER icon
133
Teradyne
TER
$58.5B
$1.81M 0.26%
60,412
-765
-1% -$25.7K
IBM icon
134
IBM
IBM
$194B
$1.81M 0.26%
12,279
-5,661
-32% -$853K
SNX icon
135
TD Synnex
SNX
$19.8B
$1.77M 0.25%
29,546
+1,012
+4% +$56.6K
RTN
136
DELISTED
Raytheon Company
RTN
$1.77M 0.25%
10,940
+6,758
+162% +$1.07M
USNA icon
137
Usana Health Sciences
USNA
$386M
$1.76M 0.25%
27,535
+19,969
+264% +$1.23M
HAS icon
138
Hasbro
HAS
$12.4B
$1.75M 0.25%
15,720
+147
+0.9% +$15.2K
PNC icon
139
PNC Financial Services
PNC
$99.5B
$1.75M 0.25%
14,027
+4,478
+47% +$540K
CHE icon
140
Chemed
CHE
$6.68B
$1.75M 0.25%
8,559
+627
+8% +$125K
PEP icon
141
PepsiCo
PEP
$184B
$1.75M 0.25%
15,162
+9,220
+155% +$1.06M
RCL icon
142
Royal Caribbean
RCL
$76B
$1.74M 0.25%
15,926
+9,331
+141% +$991K
GD icon
143
General Dynamics
GD
$103B
$1.74M 0.25%
8,757
+4,880
+126% +$956K
DLB icon
144
Dolby
DLB
$4.65B
$1.73M 0.25%
35,275
-1,905
-5% -$97.1K
IDXX icon
145
Idexx Laboratories
IDXX
$42.5B
$1.73M 0.25%
10,701
+3,923
+58% +$637K
AMGN icon
146
Amgen
AMGN
$201B
$1.71M 0.25%
9,944
+2,601
+35% +$423K
ACGL icon
147
Arch Capital
ACGL
$35B
$1.71M 0.25%
55,056
+14,034
+34% +$445K
AFL icon
148
Aflac
AFL
$63.3B
$1.71M 0.25%
44,086
+44,080
+734,667% +$1.66M
AAN.A
149
DELISTED
The Aaron's Company Inc Class A
AAN.A
$1.7M 0.24%
43,697
+19,913
+84% +$775K
TMUS icon
150
T-Mobile US
TMUS
$184B
$1.7M 0.24%
27,983
+6,636
+31% +$432K

Similar funds

GAM Systematic's Q2 2017 Portfolio in Review

As of Q2 2017, GAM Systematic held 682 positions worth $697M, up 37% from $509M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

GAM Systematic deployed $170M of net new capital in Q2 2017, opening 100 new positions and adding to 341 existing holdings. Its largest new stake was DXC Technology: 43,201 shares worth $2.87M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Carlisle Companies, an estimated $1.5M trimmed.

  • GAM Systematic's largest Q2 2017 buy was DXC Technology: 43,201 shares worth $2.87M.
  • GAM Systematic added most to Baxter International in Q2 2017, an estimated $3.67M increase.
  • GAM Systematic's biggest Q2 2017 reduction was Carlisle Companies, cutting an estimated $1.5M.
  • GAM Systematic fully exited Synchrony in Q2 2017, selling an estimated $1.21M.
  • GAM Systematic's ten largest holdings make up 6.5% of its $697M portfolio in Q2 2017.
  • GAM Systematic opened 100 new positions and closed 109 in Q2 2017.
  • GAM Systematic's portfolio value rose 37% quarter-over-quarter to $697M.

Based on GAM Systematic's 13F filing for Q2 2017, filed 14 Aug 2017.